Eyal Flom
Director/Board Member at INNOCAN PHARMA CORPORATION
Net worth: 501 183 $ as of 2024-05-30
Profile
Eyal Flom is currently the Director at Revium Recovery, Inc. He is also the Secretary & Director at InnoCan Pharma Corp.
and the Director at NurExone Biologic Ltd.
In the past, he served as the Legal Counsel at the Israeli Pharmaceutical Association.
Mr. Flom's former job includes being the Director at NurExone Biologic, Inc. Mr. Flom holds an MBA from the University of Derby and a graduate degree from Tel-Aviv University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-24 | 2,375,277 ( 0.89% ) | 501 183 $ | 2024-05-30 |
Eyal Flom active positions
Companies | Position | Start |
---|---|---|
INNOCAN PHARMA CORPORATION | Director/Board Member | 2019-09-24 |
REVIUM RECOVERY INC. | Director/Board Member | - |
Israeli Pharmaceutical Association | General Counsel | 1995-03-31 |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Director/Board Member | - |
Former positions of Eyal Flom
Companies | Position | End |
---|---|---|
NUREXONE BIOLOGIC INC. | Director/Board Member | 2023-05-07 |
Training of Eyal Flom
University of Derby | Masters Business Admin |
Tel-Aviv University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
INNOCAN PHARMA CORPORATION | Health Technology |
NUREXONE BIOLOGIC INC. | Health Technology |
REVIUM RECOVERY INC. | Distribution Services |
Private companies | 2 |
---|---|
Israeli Pharmaceutical Association | |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Health Technology |
- Stock Market
- Insiders
- Eyal Flom